Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 8/20 | 0.71 |
| ▸ | ESR2 | Q92731 | 8/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | APEX1 | P27695 | 1/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.64 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.64 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.64 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.64 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | XBP1 | P17861 | 1/20 | 0.57 |
| ▸ | GUSB | P08236 | 4/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11120379 | 0.89 | ESR1 (0.57) | ESR1ESR2MEN1POLBKMT2A | |
| Demethoxymatteucinol SCHEMBL29204370 | 0.89 | ABCG2 (0.64) | ESR1ESR2MEN1POLBKMT2A | |
| Demethoxymatteucinol SCHEMBL664144 | 0.89 | ABCG2 (0.64) | ESR1ESR2MEN1POLBKMT2A | |
| SCHEMBL7543177 | 0.87 | CYP1A1 (0.57) | ESR1ESR2MEN1POLBKMT2A | |
| SCHEMBL29776987 | 0.87 | CYP1A1 (0.57) | ESR1ESR2MEN1POLBKMT2A | |
| SCHEMBL1201860 | 0.87 | ESR1 (0.55) | ESR1ESR2MEN1POLBKMT2A | |
| SCHEMBL1200443 | 0.87 | ESR1 (0.55) | ESR1ESR2MEN1POLBKMT2A | |
| Cyrtominetin SCHEMBL1201687 | 0.85 | POLB (0.62) | ESR1ESR2MEN1POLBKMT2A | |
| Cyrtominetin SCHEMBL29657275 | 0.85 | POLB (0.62) | ESR1ESR2MEN1POLBKMT2A | |
| Cyrtominetin SCHEMBL30846161 | 0.85 | POLB (0.62) | ESR1ESR2MEN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 334 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115058451-B | Double-report plasmid for homologous recombination and single-base editing, and construction method and application thereof | 五邑大学 | 2025-01-07 | — | — | CN | claimed |
| CN-118480578-A | Nucleic acid molecule, cell line, construction method and detection method for detecting NHEJ repair and HDR repair in CRISPR-Cas gene editing | 苏州金唯智生物科技有限公司 | 2024-08-13 | — | — | CN | claimed |
| CN-116694560-A | Culture medium containing azalea essence and SCR7 for improving developmental defect of somatic cell nuclear transfer embryo and application thereof | 上海市第一妇婴保健院 | 2023-09-05 | — | — | CN | claimed |
| CN-116042513-A | Culture medium containing azalea essence for improving developmental defect of somatic cell nuclear transfer embryo and application thereof | 上海市第一妇婴保健院 | 2023-05-02 | — | — | CN | claimed |
| CN-110372767-B | Method for extracting and separating white rhododendron from rhododendron roseum leaves | 西北师范大学 | 2023-03-24 | — | — | CN | claimed |
| CN-113087749-B | Novel farrerol glycoside free radical inhibitor in saxifrage tangutica, and separation preparation process and application thereof | 中国科学院西北高原生物研究所 | 2023-03-10 | — | — | CN | claimed |
| CN-115501223-A | Application of farrerol in preparation of medicine for resisting cerebral ischemia reperfusion injury | 青岛大学 | 2022-12-23 | — | — | CN | claimed |
| CN-115501222-A | Application and method of farrerol for promoting somatic cell nuclear transfer efficiency | 同济大学 | 2022-12-23 | — | — | CN | claimed |
| CN-113417055-B | Interwoven fabric of cotton fiber, spandex fiber and polyester fiber and production method | 衣拉拉集团股份有限公司 | 2022-11-04 | — | — | CN | claimed |
| CN-114848544-A | Skin care product for repairing skin after being exposed to sun and preparation method thereof | 胡亮亮 | 2022-08-05 | — | — | CN | claimed |
| CN-101384246-A | External preparation for skin containing flavanone derivative | POLA CHEM IND INC (JP) | 2009-03-11 | — | — | CN | claimed |
| US-20090030070-A1 | EXTERNAL PREPARATION FOR SKIN CONTAINING FLAVANONE DERIVATIVE | POLA CHEMICAL INDUSTRIES INC. | 2009-01-29 | — | — | US | claimed |
| EP-1987810-A1 | EXTERNAL PREPARATION FOR SKIN CONTAINING FLAVANONE DERIVATIVE | Pola Chemical Industries Inc. (JP) | 2008-11-05 | — | — | EP | claimed |
| CN-101066245-A | Orally taken emulsion and its prepn | ZHU FANGHAI (CN) | 2007-11-07 | — | — | CN | claimed |
| CN-1634324-A | Dahurian rhododendron leaf extract and extracting method thereof | LI QINGSHAN (CN) | 2005-07-06 | — | — | CN | claimed |
| CN-1370527-A | Toxoprotein, medicament for toxoprotein caused disease and the disease preventing and treating method | CHEN JIANCAO (CN) | 2002-09-25 | — | — | CN | claimed |
| CN-1228976-A | Compound cordyceps sinensis cough and asthma syrup | LI KEQIANG (CN) | 1999-09-22 | — | — | CN | claimed |
| CN-1191130-A | Anti-AIDS virus, anti-Treponema pallidum, anti-gonococcus, anti-candida albicans and anti-trichomonas natural drug | LEI XUEJUN (CN) | 1998-08-26 | — | — | CN | claimed |
| CN-1124653-A | Natural medicine for resisting pyloric Helicobacterium | LEI XUEJUN (CN) | 1996-06-19 | — | — | CN | claimed |
| EP-0122053-A2 | Pharmaceutical compositions containing compounds with a flavanone skeleton and process for the preparation of said compounds | INVERNI DELLA BEFFA S.P.A. (IT) | 1984-10-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030070-A1 | EXTERNAL PREPARATION FOR SKIN CONTAINING FLAVANONE DERIVATIVE | COL14A1, FIBP, COL1A1 | ESR1 2928/4885ESR2 2675/4885MEN1 4555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.